| Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer K Polom, L Marano, D Marrelli, R De Luca, G Roviello, V Savelli, P Tan, ... Journal of British Surgery 105 (3), 159-167, 2018 | 253 | 2018 |
| Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review FE von Eyben, G Roviello, T Kiljunen, C Uprimny, I Virgolini, K Kairemo, ... European journal of nuclear medicine and molecular imaging 45, 496-508, 2018 | 196 | 2018 |
| The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 G De Manzoni, D Marrelli, GL Baiocchi, P Morgagni, L Saragoni, ... Gastric Cancer 20, 20-30, 2017 | 178 | 2017 |
| Apatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer G Roviello, A Ravelli, K Polom, R Petrioli, L Marano, D Marrelli, F Roviello, ... Cancer letters 372 (2), 187-191, 2016 | 162 | 2016 |
| Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer N Sobhani, A D’Angelo, M Pittacolo, G Roviello, A Miccoli, SP Corona, ... Cells 8 (4), 321, 2019 | 128 | 2019 |
| Strong prognostic value of microsatellite instability in intestinal type non-cardia gastric cancer D Marrelli, K Polom, V Pascale, C Vindigni, R Piagnerelli, L De Franco, ... Annals of surgical oncology 23, 943-950, 2016 | 116 | 2016 |
| The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials G Roviello, T Bachelot, CA Hudis, G Curigliano, AR Reynolds, R Petrioli, ... European journal of cancer 75, 245-258, 2017 | 106 | 2017 |
| The prognostic value of PI3K mutational status in breast cancer: A meta‐analysis N Sobhani, G Roviello, SP Corona, M Scaltriti, A Ianza, M Bortul, ... Journal of cellular biochemistry 119 (6), 4287-4292, 2018 | 104 | 2018 |
| Surgical management of advanced gastric cancer: An evolving issue L Marano, K Polom, A Patriti, G Roviello, G Falco, A Stracqualursi, ... European Journal of Surgical Oncology (EJSO) 42 (1), 18-27, 2016 | 104 | 2016 |
| Tumor-infiltrating lymphocytes and breast cancer: beyond the prognostic and predictive utility A Ravelli, G Roviello, D Cretella, A Cavazzoni, A Biondi, MR Cappelletti, ... Tumor Biology 39 (4), 1010428317695023, 2017 | 101 | 2017 |
| Apatinib for the treatment of gastric cancer G Roviello, A Ravelli, AI Fiaschi, MR Cappelletti, A Gobbi, C Senti, ... Expert Review of Gastroenterology & Hepatology 10 (8), 887-892, 2016 | 86 | 2016 |
| Methylene blue—current knowledge, fluorescent properties, and its future use T Cwalinski, W Polom, L Marano, G Roviello, A D’Angelo, N Cwalina, ... Journal of clinical medicine 9 (11), 3538, 2020 | 82 | 2020 |
| Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis A Tartarone, G Roviello, R Lerose, R Roudi, M Aieta, P Zoppoli Future Oncology 15 (20), 2423-2433, 2019 | 78 | 2019 |
| c-Met targeting in advanced gastric cancer: An open challenge L Marano, R Chiari, A Fabozzi, F De Vita, V Boccardi, G Roviello, ... Cancer letters 365 (1), 30-36, 2015 | 76 | 2015 |
| MSI and EBV positive gastric cancer’s subgroups and their link with novel immunotherapy MG Rodriquenz, G Roviello, A D’Angelo, D Lavacchi, F Roviello, K Polom Journal of clinical medicine 9 (5), 1427, 2020 | 67 | 2020 |
| Role of ATP-binding cassette transporters in cancer initiation and progression S Nobili, A Lapucci, I Landini, M Coronnello, G Roviello, E Mini Seminars in cancer biology 60, 72-95, 2020 | 67 | 2020 |
| Angiogenesis inhibitors in gastric and gastroesophageal junction cancer G Roviello, R Petrioli, L Marano, K Polom, D Marrelli, A Perrella, ... Gastric Cancer 19, 31-41, 2016 | 60 | 2016 |
| Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of … G Roviello, S Sigala, S Sandhu, A Bonetta, MR Cappelletti, L Zanotti, ... European Journal of Cancer 61, 111-121, 2016 | 59 | 2016 |
| Focus on ROS1-positive non-small cell lung cancer (NSCLC): crizotinib, resistance mechanisms and the newer generation of targeted therapies A D’Angelo, N Sobhani, R Chapman, S Bagby, C Bortoletti, M Traversini, ... Cancers 12 (11), 3293, 2020 | 57 | 2020 |
| The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer M Salati, R Filippi, C Vivaldi, F Caputo, F Leone, F Salani, K Cerma, ... Liver International 40 (3), 704-711, 2020 | 47 | 2020 |
Karol PolomGdansk Medical UniversityZweryfikowany adres z gumed.edu.pl
